Do DSM classifications help or hinder
drug development?


Development and regulatory approval of psychotropic drugs targets individuals with syndromes described in the current Diagnostic and Statistical Manual of Mental Disorders (DSM). This helps drug developers and regulators to communicate with prescribers, and prescribers to match a specific psychotrop...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidson, Michael, Gabos-Grecu, Cristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365297/
https://www.ncbi.nlm.nih.gov/pubmed/32699507
http://dx.doi.org/10.31887/DCNS.2020.22.1/mdavidson

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365297/
https://www.ncbi.nlm.nih.gov/pubmed/32699507
http://dx.doi.org/10.31887/DCNS.2020.22.1/mdavidson

Ejemplares similares